Roche set to sell record $14 billion euro, sterling bonds

LONDON (Reuters) – Swiss drugmaker Roche is set to raise more than $14 billion in the euro and sterling bond market and now has almost three-quarters of the financing it needs for its $42 billion hostile offer for Genentech .

Leave a Reply